← All trials
NCT03089086
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2017
- Primary completion
- Jun 30, 2018
- Completion date
- Jul 31, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 44000
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of AdelaideLead sponsor
- University of AdelaideOverall official - principal investigator
- University of AdelaideReponsible party - principal investigator
- SA Health, South Australia, AustraliaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.